Rezolute Inc (RZLT)

Sector:
INFORMATION TECHNOLOGY
Industry:
SOFTWARE
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Nevan C. Elam
Employees:
40
1450 INFINITE DRIVE, LOUISVILLE, CO 80027
650-847-1919

Rezolute, Inc. develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulini® an ultra-rare pediatric genetic disorder.

Data derived from most recent annual or quarterly report
Market Cap 43.253 Million Shares Outstanding53.73 Million Avg 30-day Volume 46.957 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.19
Price to Revenue0.0 Debt to Equity0.0 EBITDA-62.052 Million
Price to Book Value0.6552 Operating Margin0.0 Enterprise Value-39.014 Million
Current Ratio14.266 EPS Growth0.308 Quick Ratio13.722
1 Yr BETA 0.8775 52-week High/Low 2.9 / 0.72 Profit Margin0.0
Operating Cash Flow Growth-16.1829 Free Cash Flow to Firm (FCFF) TTM -41.102 Million Free Cash Flow to Equity (FCFE) TTM-43.263 Million
Altman Z-Score0.114
Earnings Report2024-02-09

Are you looking for this stock instead?

View SEC Filings from RZLT instead.

View recent insider trading info

Rezolute Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding RZLT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding RZLT

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-07-06 by ROBERTS BRIAN KENNETH
  • 4: filed on 2022-06-28 by KIM YOUNG-JIN
  • 4: filed on 2022-06-27 by FAUCHET PHILIPPE
  • 4: filed on 2022-06-27 by ROBERTS BRIAN KENNETH
  • 4: filed on 2022-06-27 by HOGENHUIS WLADIMIR
  • 4: filed on 2022-06-27 by ELAM NEVAN C
  • 4: filed on 2022-06-27 by LABRUCHERIE GIL M
  • 4: filed on 2022-06-27 by KREHER NERISSA
  • 4: filed on 2022-05-19 by ROBERTS BRIAN KENNETH
  • 4/A: filed on 2022-05-09 by LABRUCHERIE GIL M

    • Events (8k)

  • 8-K: filed on 2023-11-22:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-11-13:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-10-18:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-10-13:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-09-14:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-06-27:
    Item 7.01: Regulation FD Disclosure
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-06-20:
    Item 7.01: Regulation FD Disclosure
  • 8-K: filed on 2023-06-02:
    Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-26:
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-11:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    ROBERTS BRIAN KENNETH CHIEF MEDICAL OFFICER

    • Officer
    		 27,552 2023-07-03 1

    ELAM NEVAN C CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 2,600,000 2022-06-23 0

    LABRUCHERIE GIL M

    • Director
    		 80,000 2022-06-23 0

    KREHER NERISSA

    • Director
    		 80,000 2022-06-23 0

    HOGENHUIS WLADIMIR

    • Director
    		 80,000 2022-06-23 0

    KIM YOUNG-JIN

    • Director
    		 40,000 2022-06-23 0

    FAUCHET PHILIPPE

    • Director
    		 80,000 2022-06-23 0

    HANDOK, INC.

    • 10% Owner
    		 102,665,019 2020-10-12 0

    LIM JUNGHEE

    • Director
    		 0 2019-11-20 0

    MANTRIPRAGADA SANKARAM CHIEF SCIENTIFIC OFFICER

    • Officer
    		 0 2019-07-31 0

    VENDOLA KEITH A. CHIEF FINANCIAL OFFICER

    • Officer
    		 0 2019-07-31 0

    GENEXINE INC.

    • 10% Owner
    		 148,119,108 2019-04-26 0

    MILLER SELINE E. VP FINANCE & CAO

    • Officer
    		 0 2019-03-04 0

    SUNG YOUNG CHUL

    • Director
    		 1,250,000 2019-02-11 0

    XOMA CORP

    • 10% Owner
    		 8,093,010 2018-04-23 0

    WELCH DAVID F

    • Director
    		 1,826,415 2017-03-08 0

    HUH HOYOUNG CHAIRMAN, SCIENTIFIC ADV. BD.

    • Officer
    • Director
    		 0 2016-10-31 0

    FIELDS MORGAN CHIEF ACCOUNTING OFFICER

    • Officer
    		 0 2016-10-31 0

    SHERMAN BARRY MICHAEL

    • Director
    		 0 2016-10-31 0

    HOWE STEVE

    • Director
    		 0 2014-04-30 0

    DOCKERY CARL

    ALPHA ADVISORS, LLC

    ALPHA VENTURE CAPITAL PARTNERS, L.P.

    • 10% Owner
    • SEE REMARKSSEE REMARKS
    		1,152,847 2014-04-01 0

    KONUS ADVISORY GROUP, INC.

    • 10% Owner
    		 5,057,693 2014-03-26 0

    WOLKIN ORIT

    • 10% Owner
    		 0 2012-09-04 0

    KAEYO INVESTMENTS LTD

    • 10% Owner
    		 0 2012-09-04 0

    CHU JUE MIN

    • 10% Owner
    		 0 2012-09-04 0

    TURNOWSKI GUY SECRETARY

    • Officer
    • Director
    		 0 2012-09-04 0

    BAR NIR PRESIDENT AND TREASURER

    • Officer
    • Director
    • 10% Owner
    		 0 2012-09-04 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    REZOLUTE INC RZLT 2023-12-05 19:15:04 UTC 4.0898 1.2302 65000
    REZOLUTE INC RZLT 2023-12-05 18:45:04 UTC 4.0898 1.2302 65000
    REZOLUTE INC RZLT 2023-12-05 18:15:03 UTC 4.0898 1.2302 65000
    REZOLUTE INC RZLT 2023-12-05 17:45:04 UTC 4.0898 1.2302 65000
    REZOLUTE INC RZLT 2023-12-05 17:15:04 UTC 4.0898 1.2302 65000
    REZOLUTE INC RZLT 2023-12-05 16:45:04 UTC 4.0898 1.2302 65000
    REZOLUTE INC RZLT 2023-12-05 16:15:04 UTC 4.0898 1.2302 65000
    REZOLUTE INC RZLT 2023-12-05 15:45:04 UTC 4.0898 1.2302 65000
    REZOLUTE INC RZLT 2023-12-05 15:15:05 UTC 4.0898 1.2302 65000
    REZOLUTE INC RZLT 2023-12-05 14:45:03 UTC 4.0898 1.2302 65000
    REZOLUTE INC RZLT 2023-12-05 14:15:04 UTC 4.0898 1.2302 65000
    REZOLUTE INC RZLT 2023-12-05 13:45:04 UTC -1.4799 6.7999 65000
    REZOLUTE INC RZLT 2023-12-05 13:15:04 UTC -1.4799 6.7999 65000
    REZOLUTE INC RZLT 2023-12-05 12:45:05 UTC -1.4799 6.7999 65000
    REZOLUTE INC RZLT 2023-12-04 22:15:04 UTC -1.4799 6.7999 60000
    REZOLUTE INC RZLT 2023-12-04 21:45:03 UTC -1.4799 6.7999 60000
    REZOLUTE INC RZLT 2023-12-04 21:15:03 UTC -1.4799 6.7999 60000
    REZOLUTE INC RZLT 2023-12-04 20:45:04 UTC -1.4799 6.7999 60000
    REZOLUTE INC RZLT 2023-12-04 20:15:05 UTC -1.4799 6.7999 60000
    REZOLUTE INC RZLT 2023-12-04 19:45:03 UTC -1.4799 6.7999 60000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments